Organogenesis Holdings Inc. (ORGO) Cash Flow Statement
Organogenesis Holdings Inc. (ORGO) generated $32.0M of operating cash flow over the twelve months to 2026-06-30, spent $11.1M on capital expenditure and had free cash flow of $20.8M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ORGOOrganogenesis Holdings Inc.Follow ORGO — free
—
Price chart with a free account
- Market cap
- 127.8M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
| Line | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -60.6 | -33.5 | 5.5 | 62.0 | 24.9 | 30.9 | 14.2 | -10.3 | 32.0 | |
| Capital expenditure | 1.9 | 6.0 | 17.7 | 31.2 | 33.9 | 24.4 | 10.0 | 14.2 | -11.1 | |
| Free cash flow | -62.5 | -39.5 | -12.2 | 30.8 | -9.0 | 6.6 | 4.2 | -24.5 | 20.8 | |
| Dividends paid | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Share repurchases | — | — | — | — | — | — | 25.5 | — | — | |
| Stock-based compensation | 1.1 | 0.9 | 1.7 | 3.9 | 6.6 | 9.0 | 10.6 | 13.3 | — |
USD millions · SEC XBRL
Organogenesis Holdings Inc. — questions
- What is Organogenesis Holdings Inc.'s operating cash flow?
- $32.0M over the twelve months to 2026-06-30.
- How much does Organogenesis Holdings Inc. spend on capital expenditure?
- $11.1M over the twelve months to 2026-06-30.
- What is Organogenesis Holdings Inc.'s free cash flow?
- $20.8M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Organogenesis Holdings Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.